Ardent Health Inc (NYSE: ARDT) is a healthcare company that operates hospitals and healthcare facilities across the United States. It provides a range of services, including inpatient and outpatient care, emergency services, and specialty care. Ardent Health competes with other healthcare providers like HCA Healthcare and Tenet Healthcare. Recently, KeyBanc downgraded ARDT from an Overweight rating to a Sector Weight rating, with the stock priced at $9.01 at the time.

The downgrade follows Ardent Health's disappointing third-quarter earnings report. The company reported a quarterly loss of 17 cents per share, missing the analyst consensus estimate of a 41-cent profit per share. This earnings miss led to a reduction in the company's FY2025 GAAP EPS guidance from a range of $1.73-$2.01 to a lower range of $0.85-$1.03. Despite this, Ardent Health's quarterly sales exceeded expectations, reaching $1.577 billion compared to the expected $1.547 billion.

Marty Bonick, President and CEO of Ardent Health, pointed out some positive trends despite the earnings miss. Admissions increased by 5.8%, and adjusted admissions rose by 2.9%, nearing the high end of their 2025 guidance. Total surgeries also turned positive for the first time this year, increasing by 1.4%. Additionally, revenue and adjusted EBITDA saw significant growth, rising by 9% and 46%, respectively.

The stock for ARDT is currently priced at $9.01, reflecting a decrease of 3.12% or $0.29. Today, the stock has fluctuated between a low of $8.85 and a high of $9.35. Over the past year, the stock has reached a high of $17.34 and a low of $8.85. ARDT has a market capitalization of approximately $1.29 billion, with a trading volume of 1,914,069 shares on the NYSE.